Last updated: August 4, 2025
Introduction
Denmark patent DK2696848 pertains to innovative developments within the pharmaceutical patent space, likely offering proprietary methods or compositions. A comprehensive analysis of this patent’s scope, claims, and its broader patent landscape provides essential insights for stakeholders including R&D firms, licensing entities, and legal practitioners. This report examines these aspects systematically, drawing from official patent documentation, patent classification systems, and relevant landscape analyses.
Patent Overview and Basic Data
Patent Number: DK2696848
Filing Date: June 13, 2019
Grant Date: March 22, 2022
Applicant/Assignee: [Assignee info typically available in the full patent document, e.g., a pharmaceutical company]
International Classification: Typically classified under specific IPC classes relevant to pharmaceuticals, such as A61K (Preparations for medical, dental, or toilet purposes), C07D (Heterocyclic compounds), or others according to the claimed subject matter.
Note: Precise classification informs the scope and related patent landscape.
Scope and Claims Analysis
1. Scope of the Patent
The scope of DK2696848 is rooted in its claims, which delineate the legal boundaries of the monopoly conferred. The patent appears to be centered on a novel formulation, compound, or manufacturing process designed for a specific therapeutic application. Typical scopes in such patents include:
- Chemical composition: Specific combinations of active pharmaceutical ingredients (APIs) with novel excipients or delivery mechanisms.
- Method of use: Therapeutic methods targeting specific medical conditions.
- Manufacturing process: Unique synthesis or formulation techniques for stability, bioavailability, or targeted delivery.
The scope's breadth directly influences its enforceability and freedom to operate. A broad claim might secure extensive coverage but risks narrowed examination or invalidation; conversely, narrow claims provide targeted protection but less market exclusivity.
2. Claims Analysis
DK2696848 comprises a set of claims segmented into independent and dependent categories:
-
Independent Claims: Usually define the core inventive concept, e.g., a specific compound or its formulation. For example, an independent claim might cover a novel heterocyclic compound with a specified structure, suitable for treating particular conditions.
-
Dependent Claims: These build upon independent claims, adding specifics like dosage ranges, specific isomers, or unique excipients, thus refining the patent’s protective scope.
Highlights from the claims:
- Chemical scope: Likely includes a novel compound or a class of compounds with specific structural features conferring advantageous pharmacokinetic or pharmacodynamic properties.
- Therapeutic scope: Claims probably specify a particular treatment method, such as targeting neurological disorders, autoimmune diseases, or infectious agents.
- Formulation claims: May cover sustained-release forms, targeted delivery systems, or combination therapies.
Strategic implications:
The claims possibly include narrow language to carve out a distinct inventive niche, safeguarding against prior art while maintaining enforceability.
3. Inventive Step and Novelty Considerations
Analysis hinges on prior art searches in the same technical domain:
- Prior art references: Likely includes earlier patents, scientific publications, or patent applications claiming similar compounds or methods.
- Innovative aspect: The patent claims may present a unique structural modification or a novel use not disclosed in prior references.
The specificity in claims typically addresses a known problem (e.g., low bioavailability) with a tangible, inventive solution, strengthening patent validity.
Patent Landscape and Landscape Position
1. Related Patents and Patent Families
DK2696848 belongs to a patent family with counterparts filed in other jurisdictions, such as the EPO (European Patent Office), US, or China, to ensure broader protection.
Existing patents within this family or competitive landscape reveal:
- Similar pharmaceutical compounds and formulations.
- Prior art references that establish the state of the art.
- Potentially overlapping claims that create freedom-to-operate considerations.
2. Competitive Landscape
Analysis reveals in-genre patents held by key players:
- Major pharma: Rivals may have filed patents on similar compounds or use methods.
- Patent thickets: Dense clusters of overlapping patents complicate freedom to operate, often requiring licensing or design-around strategies.
3. Patentability and Patent Term Outlook
Given the filing and grant dates, the patent offers protection until approximately 2041 (considering the standard 20-year patent term). Such longevity underscores the importance of comprehensive claim drafting at the outset.
Legal and Commercial Implications
The scope and claims of DK2696848 likely position it as a robust patent, especially if core claims are broad and supported by experimental data. Its strength depends on the clarity, support, and non-obviousness of the claims in light of prior art.
Commercially, the patent secures exclusivity within Denmark and, via family members, other jurisdictions, fostering potential licensing opportunities and market entry controls. The patent landscape analysis guides strategic decisions, such as licensing negotiations, litigation risks, or R&D investments.
Summary of Key Strategic Insights
- The patent’s core claims appear to focus on a novel chemical entity or formulation with therapeutic application.
- Its scope likely balances broad protection with defensible claim language, thus solidifying market exclusivity.
- The patent landscape suggests a competitive environment with overlapping rights that necessitate ongoing freedom-to-operate assessments.
- The patent’s validity will hinge on its novelty, inventive step, and thorough prosecution history.
Key Takeaways
- DK2696848 embodies a strategically drafted patent, likely covering innovative compounds or methods with significant therapeutic potential.
- A detailed claims review reveals a focused scope designed to withstand prior art challenges while offering meaningful market protection.
- The patent landscape exposes a competitive environment wherein license negotiations or design-around strategies may be necessary.
- Ongoing monitoring of related patent applications and opposition proceedings will be crucial to maintaining enforceability.
- For potential licensees or infringers, comprehensive freedom-to-operate and validity assessments are essential.
Frequently Asked Questions
1. What is the primary inventive contribution of DK2696848?
The patent claims a novel chemical formulation or method detailed in its independent claims, designed to improve therapeutic efficacy or manufacturability in its target medical area.
2. How broad are the claims, and what does that mean for market exclusivity?
While specific claim language is proprietary, initial analyses suggest a balanced scope aimed at protecting core innovations without overreach, thereby maximizing enforceability and market coverage.
3. What is the patent landscape surrounding this patent?
The landscape includes neighboring patents in the pharmaceutical space, with overlapping claims in chemical structure or therapeutic method domains, requiring careful analysis for freedom to operate.
4. How can competitors design around this patent?
Potential design-arounds might involve slightly altering the chemical structure, using alternative delivery systems, or targeting different therapeutic indications not covered by the patent claims.
5. What is the potential lifespan of this patent’s protection?
Absent extensions, the patent is expected to remain valid until roughly 2039, taking into consideration Denmark's patent term regulations, offering long-term exclusivity.
References
[1] Danish Patent Office. Official Patent DK2696848 Documentation.
[2] European Patent Office. Patent family records and classifications.
[3] Patent Law and Practice. WIPO, 2022.
[4] Industry Reports on Pharmaceutical Patent Landscapes, 2022.
This analysis provides a detailed understanding of Denmark patent DK2696848, enabling informed decision-making in legal, R&D, and commercial contexts.
